Work

COBRA: Assessment of the efficacy of 64 Cu-SAR-bisPSMA using histopathology as reference standard in patients with biochemical recurrence of prostate cancer following definitive therapy.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.44

Authors: Luke Nordquist, Eva Lengyelova, Daniel R. Saltzstein, David Josephson, Gregg Franklin, Glynn Morrish, Othon Gervasio, Robert M. Miller, Neal D. Shore

Institutions: Clarity Pharmaceuticals Ltd. (Australia), Urology San Antonio, Tower Urology Medical Group, New Mexico Cancer Center, Carolina Urologic Research Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407699405

Cites:

Cited by: 1

Related to: 10